CompletedNot Applicable

Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block

United States32 participantsStarted 2017-07-17

Plain-language summary

This study will compare the analgesic benefit of a traditional landmark-guided GON block with the ultrasound-guided approach over a four week period in patients with occipital neuralgia or cervicogenic headache.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Unilateral or bilateral headache symptoms attributed to occipital neuralgia or cervicogenic headache as defined by the International Headache Society's International Classification of Headache Disorders (3rd edition beta version)
✓. Age 18 years and older (no upper age limit defined)
✓. Imaging of cervical spine within last year (either x-ray, MRI or CT)

Exclusion criteria

✕. History of cervical spine surgery, trauma, or surgical procedure involving head or neck during the last year
✕. Use of new preventative medications 1 month prior or during study enrollment
✕. Evidence of impaired sensation in the GON dermatome region (posterior scalp to the vertex of the cranium) from neurological, dermatological, or other disease process
✕. Evidence of cranial defect or other anatomical abnormality near the target injection site
✕. History of bleeding diathesis, coagulopathy, or current use of anticoagulant medications
✕. Pregnancy
✕. History of adverse reaction or allergy to local anesthetic agents or corticosteroids
✕. Occipital nerve block within the past three months.

What they're measuring

Change in Numeric Rating Scale (NRS) Pain Score

Timeframe: baseline, 4 weeks

Trial details

NCT IDNCT03478735

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-06-14

View on ClinicalTrials.gov More Occipital Neuralgia trials